471 related articles for article (PubMed ID: 12218081)
1. Preferential loss of Fhit expression in signet-ring cell and Krukenberg subtypes of gastric cancer.
Chang YT; Wu MS; Chang CJ; Huang PH; Hsu SM; Lin JT
Lab Invest; 2002 Sep; 82(9):1201-8. PubMed ID: 12218081
[TBL] [Abstract][Full Text] [Related]
2. Loss of heterozygosity and microsatellite instabilities of fragile histidine triad gene in gastric carcinoma.
Xiao YP; Wu DY; Xu L; Xin Y
World J Gastroenterol; 2006 Jun; 12(23):3766-9. PubMed ID: 16773697
[TBL] [Abstract][Full Text] [Related]
3. FHIT gene in gastric cancer: association with tumour progression and prognosis.
Noguchi T; Müller W; Wirtz HC; Willers R; Gabbert HE
J Pathol; 1999 Aug; 188(4):378-81. PubMed ID: 10440747
[TBL] [Abstract][Full Text] [Related]
4. High frequency of LOH, MSI and abnormal expression of FHIT in gastric cancer.
Huiping C; Kristjansdottir S; Bergthorsson JT; Jonasson JG; Magnusson J; Egilsson V; Ingvarsson S
Eur J Cancer; 2002 Mar; 38(5):728-35. PubMed ID: 11916557
[TBL] [Abstract][Full Text] [Related]
5. Reduced Fhit expression in sporadic and BRCA2-linked breast carcinomas.
Ingvarsson S; Agnarsson BA; Sigbjornsdottir BI; Kononen J; Kallioniemi OP; Barkardottir RB; Kovatich AJ; Schwarting R; Hauck WW; Huebner K; McCue PA
Cancer Res; 1999 Jun; 59(11):2682-9. PubMed ID: 10363992
[TBL] [Abstract][Full Text] [Related]
6. Fhit expression in gastric adenocarcinoma: correlation with disease stage and survival.
Capuzzi D; Santoro E; Hauck WW; Kovatich AJ; Rosato FE; Baffa R; Huebner K; McCue PA
Cancer; 2000 Jan; 88(1):24-34. PubMed ID: 10618602
[TBL] [Abstract][Full Text] [Related]
7. Loss of Fhit expression in non-small-cell lung cancer: correlation with molecular genetic abnormalities and clinicopathological features.
Geradts J; Fong KM; Zimmerman PV; Minna JD
Br J Cancer; 2000 Mar; 82(6):1191-7. PubMed ID: 10735505
[TBL] [Abstract][Full Text] [Related]
8. Ovarian Metastases of Breast Cancers With Signet Ring Cells: A Report of 17 Cases Including 14 Krukenberg Tumors.
Bennett JA; Young RH; Chuang AY; Lerwill MF
Int J Gynecol Pathol; 2018 Nov; 37(6):507-515. PubMed ID: 29045292
[TBL] [Abstract][Full Text] [Related]
9. Loss of FHIT expression in gastric carcinoma.
Baffa R; Veronese ML; Santoro R; Mandes B; Palazzo JP; Rugge M; Santoro E; Croce CM; Huebner K
Cancer Res; 1998 Oct; 58(20):4708-14. PubMed ID: 9788626
[TBL] [Abstract][Full Text] [Related]
10. Ovarian metastases of intestinal-type gastric carcinoma: A clinicopathologic study of 4 cases with contrasting features to those of the Krukenberg tumor.
Lerwill MF; Young RH
Am J Surg Pathol; 2006 Nov; 30(11):1382-8. PubMed ID: 17063077
[TBL] [Abstract][Full Text] [Related]
11. Frequent allelic deletion at the FHIT locus associated with p53 overexpression in squamous cell carcinoma subtype of Taiwanese non-small-cell lung cancers.
Lee YC; Wu CT; Shih JY; Jou YS; Chang YL
Br J Cancer; 2004 Jun; 90(12):2378-83. PubMed ID: 15150628
[TBL] [Abstract][Full Text] [Related]
12. Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer.
Fullwood P; Marchini S; Rader JS; Martinez A; Macartney D; Broggini M; Morelli C; Barbanti-Brodano G; Maher ER; Latif F
Cancer Res; 1999 Sep; 59(18):4662-7. PubMed ID: 10493522
[TBL] [Abstract][Full Text] [Related]
13. Altered expression of the fragile histidine triad gene in primary gastric adenocarcinomas.
Lee SH; Kim WH; Kim HK; Woo KM; Nam HS; Kim HS; Kim JG; Cho MH
Biochem Biophys Res Commun; 2001 Jun; 284(3):850-5. PubMed ID: 11396980
[TBL] [Abstract][Full Text] [Related]
14. Loss of Fhit expression is associated with poorer survival in gastric cancer but is not an independent prognostic marker.
Bragantini E; Barbi S; Beghelli S; Moore PS; de Manzoni G; Roviello F; Tomezzoli A; Vindigni C; Baffa R; Scarpa A
J Cancer Res Clin Oncol; 2006 Jan; 132(1):45-50. PubMed ID: 16217683
[TBL] [Abstract][Full Text] [Related]
15. Analysis of FHIT allelic imbalance/loss of heterozygosity and FHIT expression in cutaneous squamous cell carcinomas.
Gray SE; Kay E; Leader M; Mabruk M
J Cutan Pathol; 2008 Sep; 35(9):816-25. PubMed ID: 18494825
[TBL] [Abstract][Full Text] [Related]
16. Loss of FHIT protein expression correlates with disease progression and poor differentiation in gastric cancer.
Rocco A; Schandl L; Chen J; Wang H; Tulassay Z; McNamara D; Malfertheiner P; Ebert MP
J Cancer Res Clin Oncol; 2003 Feb; 129(2):84-8. PubMed ID: 12669232
[TBL] [Abstract][Full Text] [Related]
17. Concomitant loss of heterozygosity at the BRCA1 and FHIT genes as a prognostic factor in sporadic breast cancer.
Silva Soares EW; de Lima Santos SC; Bueno AG; Cavalli IJ; Cavalli LR; Fouto Matias JE; de Souza Fonseca Ribeiro EM
Cancer Genet Cytogenet; 2010 May; 199(1):24-30. PubMed ID: 20417865
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the fragile histidine triad (FHIT) gene in lobular breast cancer.
Huiping C; Jonasson JG; Agnarsson BA; Sigbjornsdottir BI; Huebner K; Ingvarsson S
Eur J Cancer; 2000 Aug; 36(12):1552-7. PubMed ID: 10930803
[TBL] [Abstract][Full Text] [Related]
19. Primary ovarian mucinous tumors with signet ring cells: report of 3 cases with discussion of so-called primary Krukenberg tumor.
McCluggage WG; Young RH
Am J Surg Pathol; 2008 Sep; 32(9):1373-9. PubMed ID: 18670351
[TBL] [Abstract][Full Text] [Related]
20. Alterations of the FHIT gene in breast cancer: association with tumor progression and patient survival.
Ingvarsson S; Sigbjornsdottir BI; Huiping C; Jonasson JG; Agnarsson BA
Cancer Detect Prev; 2001; 25(3):292-8. PubMed ID: 11425271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]